N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase
- PMID: 32157382
- DOI: 10.1007/s00294-020-01062-2
N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative condition characterized by a gradual loss of a specific group of dopaminergic neurons in the substantia nigra. Importantly, current treatments only address the symptoms of PD, yet not the underlying molecular causes. Concomitantly, the function of genes that cause inherited forms of PD point to mitochondrial dysfunction as a major contributor in the etiology of PD. An inherent challenge that mitochondria face is the continuous exposure to diverse stresses including high levels of reactive oxygen species and protein misfolding, which increase their likelihood of dysregulation. In response, eukaryotic cells have evolved sophisticated quality control mechanisms to identify, repair and/or eliminate abnormal dysfunctional mitochondria. One such mechanism is mitophagy, a process which involves PTEN-induced putative kinase 1 (PINK1), a mitochondrial Ser/Thr kinase and Parkin, an E3 ubiquitin ligase, each encoded by genes responsible for early-onset autosomal recessive familial PD. Over 100 loss-of-function mutations in the PTEN-induced putative kinase 1 (PINK1) gene have been reported to cause autosomal recessive early-onset PD. PINK1 acts upstream of Parkin and is essential for the mitochondrial localization and activation of Parkin. Upon mitochondrial damage, PINK1 builds up on the outer mitochondrial membrane (OMM) and mediates the activation of Parkin. Activated Parkin then ubiquitinates numerous OMM proteins, eliciting mitochondrial autophagy (mitophagy). As a result, damaged mitochondrial components can be selectively eliminated. Thus, PINK1 acts a sensor of damage via fine-tuning of its levels on mitochondria, where it activates Parkin to orchestrate the clearance of unhealthy mitochondria. Previous work has unveiled that the Arg-N-end rule degradation pathway (Arg-N-degron pathway) mediates the degradation of PINK1, and thus fine-tune PINK1-dependent mitochondrial quality control pathway. Herein, we briefly discuss the interconnection between N-end rule degradation pathways and mitophagy in the context of N-degron mediated degradation of mitochondrial kinase PINK1 and highlight some of the future prospects.
Keywords: Mitochondrial quality control; N-degron; N-end rule; PINK1; Parkinson’s disease; Proteasome; Protein degradation; Ubiquitin.
Similar articles
-
The Role of PTEN-L in Modulating PINK1-Parkin-Mediated Mitophagy.Neurotox Res. 2022 Aug;40(4):1103-1114. doi: 10.1007/s12640-022-00475-w. Epub 2022 Jun 14. Neurotox Res. 2022. PMID: 35699891 Review.
-
Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons.J Biol Chem. 2013 Jan 25;288(4):2223-37. doi: 10.1074/jbc.M112.391680. Epub 2012 Dec 4. J Biol Chem. 2013. PMID: 23212910 Free PMC article.
-
PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1-Parkin-mediated mitophagy.Cell Res. 2018 Aug;28(8):787-802. doi: 10.1038/s41422-018-0056-0. Epub 2018 Jun 22. Cell Res. 2018. PMID: 29934616 Free PMC article.
-
Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.Cell Mol Life Sci. 2019 Dec;76(23):4589-4611. doi: 10.1007/s00018-019-03203-4. Epub 2019 Jun 28. Cell Mol Life Sci. 2019. PMID: 31254044 Free PMC article. Review.
-
The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation.EMBO Rep. 2016 Mar;17(3):300-16. doi: 10.15252/embr.201541486. Epub 2016 Feb 8. EMBO Rep. 2016. PMID: 26882551 Free PMC article. Review.
Cited by
-
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.Int J Mol Sci. 2020 Sep 28;21(19):7174. doi: 10.3390/ijms21197174. Int J Mol Sci. 2020. PMID: 32998479 Free PMC article. Review.
-
Mitochondria in health, disease, and aging.Physiol Rev. 2023 Oct 1;103(4):2349-2422. doi: 10.1152/physrev.00058.2021. Epub 2023 Apr 6. Physiol Rev. 2023. PMID: 37021870 Free PMC article. Review.
-
Mitophagy-A New Target of Bone Disease.Biomolecules. 2022 Oct 4;12(10):1420. doi: 10.3390/biom12101420. Biomolecules. 2022. PMID: 36291629 Free PMC article. Review.
-
The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease.Neuromolecular Med. 2023 Dec;25(4):471-488. doi: 10.1007/s12017-023-08755-0. Epub 2023 Sep 12. Neuromolecular Med. 2023. PMID: 37698835 Review.
-
Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1.Int J Mol Sci. 2023 Aug 24;24(17):13158. doi: 10.3390/ijms241713158. Int J Mol Sci. 2023. PMID: 37685964 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials